BOONE CAPITAL MANAGEMENT LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001882053

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q3 2026 · 16 positions · Total reported value $376.70M · Top-10 concentration 81.1% · Updated 2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

Turnover: 71.4% · 5 new · 5 cut · 5 exited

Active Share (vs S&P 500): 99.4% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -7.2% · vs SPY -9.3% · Prev Value $427.54M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +6.8% · vs SPY +4.6% · Latest Value $376.70M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, BOONE CAPITAL MANAGEMENT LLC disclosed 16 equity positions with a combined reported value of $376.70M. The filing implies a focused portfolio: its ten largest positions account for 81.1% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were BMRN ($40.32M), TFX ($36.12M), MIRM ($35.53M). By sector, the heaviest allocations are Health Care 75.8%, Consumer Staples 7.8%. Versus the prior quarter, allocation shifted toward Industrials (+7.3pp), Technology (+3.4pp) and away from Consumer Discretionary (-0.8pp), Health Care (-10.8pp).

Versus the prior quarter, BOONE CAPITAL MANAGEMENT LLC opened 5 new positions, trimmed 5 and fully exited 5, a turnover rate of 71.4% of positions. The portfolio's overlap with the prior quarter was 52% of names.

The largest new positions opened in Q3 2026 were AVTR ($27.68M), LH ($26.98M), EHC ($25.01M).

Of the 5 positions fully exited versus the prior quarter, the largest were IONS ($41.23M), GLUE ($14.89M), KOD ($14.73M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • AVTR AVANTOR INC · $27.68M
  • LH LABCORP HOLDINGS INC · $26.98M
  • EHC ENCOMPASS HEALTH CORP · $25.01M
  • WAY WAYSTAR HLDG CORP · $12.89M
  • MAZE MAZE THERAPEUTICS INC · $4.88M

Fully Exited (vs previous quarter)

  • IONS IONIS PHARMACEUTICALS INC · prev qtr: $41.23M
  • GLUE MONTE ROSA THERAPEUTICS INC · prev qtr: $14.89M
  • KOD KODIAK SCIENCES INC · prev qtr: $14.73M
  • TNGX TANGO THERAPEUTICS INC · prev qtr: $14.24M
  • KYMR KYMERA THERAPEUTICS INC · prev qtr: $12.98M

Insider Transactions (Form 4)

Latest BOONE CAPITAL MANAGEMENT LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Boone Capital Management is an SEC-registered 13F filer based in Atlanta, GA, United States. As of Q3 2026 it reported 16 US equity positions with a combined value of $376.70M. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: ATLANTA, GA, United States
  • SEC registration: 801-126199 (status: Approved), registered 2022-07-27
  • Regulatory AUM (Form ADV): $963.17M as of 2026-03-30
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds

Portfolio Structure

  • 16 positions · $376.70M reported value (Q3 2026)
  • Top 10 holdings = 81.1% of reported value
  • Largest position: BMRN (BIOMARIN PHARMACEUTICAL INC) at 10.7%
  • Average position size: $23.54M

Sector Tilt

  • Health Care 75.8%
  • Consumer Staples 7.8%
  • Industrials 7.3%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q3 2026: 5 new, 3 added, 5 reduced, 5 exited
  • 3 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall direction and market view: The fund increased exposure to Health Care (70% of top-10) and added new positions, suggesting a bullish tilt toward biotech/pharma but reduced some existing holdings, indicating selective profit-taking. 2. Key moves: - Added: BMRN (+2.89% wt), GRDN (+0.88% wt) - Reduced: TFX (-1.90% wt), CI (-2.17% wt), VSTS (-0.83% wt) - New: AVTR (7.35% wt), LH (7.16% wt), EHC (6.64% wt) 3. Portfolio structure: Active, concentrated (top-10 = 72.4%), with heavy Health Care bias; moderate risk via biotech (BMRN, MIRM) and defensive staples (GRDN). 4. Per-holding one-liner: - BMRN: Biopharma (unverified: enzyme therapies) - TFX: Medical devices (unverified: procedural tools) - MIRM: Rare-disease biopharma (unverified: liver treatments) - UNH: Health insurer (unverified: managed care) - CI: Health insurer (unverified: managed care) - GRDN: Pharmacy services (unverified: specialty pharmacy) - AVTR: Lab/industrial chemicals (unverified: life sciences) - LH: Diagnostics (unverified: lab testing) - EHC: Post-acute care (unverified: rehab hospitals) - VSTS: Retail apparel (unverified: workwear) 5. Style summary: Aggressive Health Care focus with new biotech/diagnostics bets and selective trims in non-core positions.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-17 12:05

Sector Allocation

Health Care 75.8%
Technology 3.4%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 672.00K $40.32M 10.70%
10.70%
Add
2 288.90K $36.12M 9.59%
9.59%
Reduce
3 415.64K $35.53M 9.43%
9.43%
Hold
4 88.69K $32.56M 8.64%
8.64%
Hold
5 112.27K $30.52M 8.10%
8.10%
Reduce
6 725.06K $29.57M 7.85%
7.85%
Add
7 1.84M $27.68M 7.35%
7.35%
New
8 87.55K $26.98M 7.16%
7.16%
New
9 205.84K $25.01M 6.64%
6.64%
New
10 1.58M $21.16M 5.62%
5.62%
Reduce
11 525.92K $20.51M 5.45%
5.45%
Add
12 277.43K $18.26M 4.85%
4.85%
Reduce
13 508.65K $12.89M 3.42%
3.42%
New
14 690.81K $10.60M 2.81%
2.81%
Reduce
15 179.50K $4.88M 1.29%
1.29%
New
16 258.39K $4.13M 1.10%
1.10%
Hold

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q3)

P 70% R 70% F1 70% (modelled on 2026-Q2; 7/10 hit)

Low-confidence forecast This fund replaces about 29% of its Top-10 each quarter and backtests at F1 69% (threshold 80%). Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.

Historical Backtest (11 quarters)

Avg precision 69% · recall 69% · F1 69% · avg rank error 2.7 · Top-10 turnover 29%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 70% 70% 70% UNM · ENOV · GMED · AMGN · CVS · CI · AMPH · DHR · MOH · BAX UNM · CI · MOH · ENOV · BAX · GMED · BERY · AMPH · VKTX · BIO
2024-Q2 60% 60% 60% UNM · CI · ENOV · MOH · BAX · BERY · AMPH · GMED · BIO · VKTX UNM · GMED · CI · MOH · DHR · BAX · IQV · AMPH · MIRM · PNTG
2024-Q3 80% 80% 80% UNM · CI · GMED · MOH · DHR · BAX · AMPH · IQV · MIRM · PNTG UNM · GMED · CI · MOH · CHE · PNTG · MIRM · DHR · IDYA · BAX
2024-Q4 70% 70% 70% UNM · GMED · CI · MOH · CHE · PNTG · MIRM · DHR · IDYA · BAX UNM · GMED · PRGO · MIRM · MOH · CI · OFIX · PNTG · BHVN · IDYA
2025-Q1 70% 70% 70% UNM · GMED · PRGO · MIRM · MOH · CI · OFIX · PNTG · IDYA · BHVN UNM · MDT · MIRM · GMED · CI · BMRN · MOH · PRGO · ISRG · PNTG
2025-Q2 60% 60% 60% UNM · MDT · MIRM · GMED · BMRN · MOH · CI · PRGO · ISRG · PNTG MDT · MIRM · BMRN · AVTR · UNM · NBIX · PNTG · UNH · ICLR · CI
2025-Q3 70% 70% 70% MDT · MIRM · BMRN · NBIX · AVTR · UNM · PNTG · UNH · ICLR · CI MDT · MIRM · IONS · CI · BBIO · NBIX · RAPT · UNH · BMRN · ICLR
2025-Q4 70% 70% 70% MDT · MIRM · IONS · CI · BBIO · NBIX · UNH · RAPT · BMRN · ICLR MDT · MIRM · IONS · CI · BMRN · NBIX · UNH · AZN · HQY · LIVN
2026-Q1 70% 70% 70% MDT · IONS · MIRM · CI · BMRN · NBIX · AZN · UNH · LIVN · HQY MIRM · IONS · CI · MDT · TFX · BMRN · GRDN · AZN · UNH · BBIO
2026-Q2 70% 70% 70% CI · IONS · MIRM · MDT · TFX · BMRN · GRDN · UNH · AZN · AVNS TFX · MIRM · CI · IONS · UNH · BMRN · GRDN · VSTS · BBIO · PNTG
2026-Q3 ★ 70% 70% 70% TFX · MIRM · CI · IONS · UNH · BMRN · GRDN · VSTS · BBIO · PNTG BMRN · TFX · MIRM · UNH · CI · GRDN · AVTR · LH · EHC · VSTS

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

Barra Factor Attribution

The disclosed long US equity book from the 2026-Q3 13F is held at its report-date weights and decomposed over 2026-09-30 ~ 2026-11-16. The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional factor returns and an EWMA factor covariance for risk. The “portfolio” is the visible 13F book, not the fund's true NAV.

13F periodQ3 2026 Attribution quarterQ4 2026 (in progress) Window2026-09-30 → 2026-11-16 Trading days33 Holdings6 Model coverage100.0%

The quarter is not complete yet; the window ends at the latest available price date, 2026-11-16, and will update as prices arrive.

Portfolio return+9.54%Buy & hold
QQQ synthetic benchmark-17.01%Liquidity weighted
Excess return+26.55%vs benchmark
Barra annualised vol26.5%Model estimate
Realised vol19.9%Annualised in window
Weighted beta0.64Raw exposure
Factor / specific risk54% / 46%Share of variance
Top-10 concentration100.0%Of reported value
Portfolio value (start = 100)77.687.196.6106.1115.510-0110-2311-16BOONE CAPITAL MANAGEMENT LLCQQQ syntheticLiquid universe EW
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.

1. Performance

Metric Value Note
Portfolio return (buy & hold)+9.54%Disclosed long book
QQQ synthetic benchmark-17.01%Liquidity-weighted constituents
Model universe, equal weight-1.70%Opportunity-cost reference
Excess return+26.55%Portfolio − benchmark
Arithmetic return sum+9.37%Difference vs compounded is the cross term
Weighted raw beta0.64Weighted holding betas
Realised volatility (annualised)19.87%Daily returns in window
Barra model volatility (annualised)26.47%Factor + specific
Factor share of variance53.8%Barra factors
Specific share of variance46.2%Stock residuals
Reported value$135.0M13F long US equity

2. Return attribution

The +9.37% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.

Factor group Factors Contribution Share of |return|
Size & Liquidity 6 -2.84% -30.3%
Momentum & Growth 3 -1.19% -12.7%
Volatility & Tail Risk 7 +5.88% 62.8%
Industry 12 +5.56% 59.3%
Specific 1 +1.97% 21.0%
Return attribution (style + industry, %)-4.9-2.5+0.0+2.5+4.9Max Drawdown+0.59Beta-1.03Consumer Discretionary+1.05Non-linear Size+1.07Size+1.21Leverage (Downside Vol)+1.33Kurtosis+1.51Momentum-1.80Turnover-2.16Mid Cap-2.43Historical Volatility+2.52Skewness-3.61Health Care+4.46Residual Volatility+4.56
Factor Type Exposure Factor return Contribution Share of |return|
Residual Volatility Style +1.39 +3.29% +4.56% 48.7%
Health Care Industry +0.64 +6.98% +4.46% 47.6%
Historical Volatility Style -0.18 -14.00% +2.52% 26.9%
Specific Specific — — +1.97% 21.0%
Kurtosis Style +0.20 +7.51% +1.51% 16.1%
Leverage (Downside Vol) Style -0.78 -1.71% +1.33% 14.2%
Size Style -0.62 -1.95% +1.21% 12.9%
Non-linear Size Style +1.06 +1.01% +1.07% 11.5%
Consumer Discretionary Industry +0.16 +6.71% +1.05% 11.2%
Max Drawdown Style -0.34 -1.76% +0.59% 6.3%
Growth Style +0.34 +1.75% +0.59% 6.3%
Liquidity Style -0.18 +0.36% -0.06% -0.7%
Amihud Illiquidity Style +1.06 -0.45% -0.47% -5.0%
Beta Style -0.23 +4.44% -1.03% -11.0%
Momentum Style +0.45 -4.00% -1.80% -19.2%
Turnover Style +0.45 -4.80% -2.16% -23.0%
Mid Cap Style +1.26 -1.94% -2.43% -25.9%
Skewness Style +0.82 -4.39% -3.61% -38.5%

3. Risk attribution

Annualised volatility is 26.47%; factor risk explains 53.8% of variance and specific risk 46.2%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.

Risk attribution (share of variance, %)-49.9-25.0+0.0+25.0+49.9Skewness-1.83Beta-1.65Growth+1.42Residual Volatility+1.48Amihud Illiquidity+2.05Max Drawdown+2.29Momentum+3.51Consumer Discretionary+3.89Size+4.11Leverage (Downside Vol)+4.54Industrials+4.63Mid Cap+8.41Health Care+19.04Specific+46.23
Factor Type Exposure Share of variance Vol contribution Share of vol
Specific Specific — 46.2% +12.24% 12.2%
Health Care Industry +0.64 19.0% +5.04% 5.0%
Mid Cap Style +1.26 8.4% +2.23% 2.2%
Industrials Industry +0.20 4.6% +1.23% 1.2%
Leverage (Downside Vol) Style -0.78 4.5% +1.20% 1.2%
Size Style -0.62 4.1% +1.09% 1.1%
Consumer Discretionary Industry +0.16 3.9% +1.03% 1.0%
Momentum Style +0.45 3.5% +0.93% 0.9%
Max Drawdown Style -0.34 2.3% +0.60% 0.6%
Amihud Illiquidity Style +1.06 2.0% +0.54% 0.5%
Residual Volatility Style +1.39 1.5% +0.39% 0.4%
Growth Style +0.34 1.4% +0.38% 0.4%
Turnover Style +0.45 0.5% +0.14% 0.1%
Non-linear Size Style +1.06 0.5% +0.12% 0.1%
Kurtosis Style +0.20 0.3% +0.09% 0.1%
Liquidity Style -0.18 0.3% +0.07% 0.1%
Historical Volatility Style -0.18 0.2% +0.06% 0.1%
Beta Style -0.23 -1.6% -0.44% -0.4%
Skewness Style +0.82 -1.8% -0.49% -0.5%

4. Style exposures

Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.

Style exposures (z-score)-1.1-0.20.71.52.4Max DrawdownKurtosisSkewnessLeverage (Downside Vol)GrowthTurnoverAmihud IlliquidityLiquidityHistorical VolatilityResidual VolatilityShort-term ReversalMomentumBetaMid CapNon-linear SizeSizePortfolioQQQ benchmark
Style factor Portfolio QQQ benchmark Difference
Size -0.62 +2.10 -2.72
Non-linear Size +1.06 +1.68 -0.61
Mid Cap +1.26 +0.13 +1.13
Beta -0.23 +1.29 -1.53
Momentum +0.45 +0.72 -0.27
Short-term Reversal +0.01 -0.64 +0.66
Residual Volatility +1.39 -0.40 +1.79
Historical Volatility -0.18 +0.86 -1.04
Liquidity -0.18 +0.11 -0.29
Amihud Illiquidity +1.06 +1.16 -0.09
Turnover +0.45 +0.21 +0.24
Growth +0.34 +0.58 -0.24
Leverage (Downside Vol) -0.78 +0.14 -0.92
Skewness +0.82 +0.24 +0.58
Kurtosis +0.20 +0.21 -0.01
Max Drawdown -0.34 -0.08 -0.25

5. Industry allocation & Brinson

Industry allocation (weight, %)-7.414.736.858.981.0Information TechnologyCommunication ServicesUtilitiesConsumer StaplesConsumer DiscretionaryIndustrialsHealth CarePortfolioQQQ benchmark
Sector Portfolio Benchmark Portfolio ret Benchmark ret Allocation Selection Interaction Total
Information Technology 0.0% 73.6% +0.00% -22.33% +3.83% +16.44% -16.44% +16.44%
Health Care 63.8% 1.7% +13.43% +8.29% +15.79% +0.09% +3.20% +8.43%
Communication Services 0.0% 2.6% +0.00% -17.64% +0.01% +0.46% -0.46% +0.46%
Consumer Discretionary 15.7% 8.8% +2.47% +3.76% +1.43% -0.11% -0.09% +0.06%
Utilities 0.0% 0.8% +0.00% +11.13% -0.22% -0.09% +0.09% -0.09%
Industrials 20.5% 11.1% +1.79% +4.36% +2.02% -0.29% -0.24% -0.12%
Consumer Staples 0.0% 0.8% +0.00% +15.26% -0.27% -0.13% +0.13% -0.13%
Total +22.47% +16.35% -13.79% +25.03%

6. Holdings & contribution

Symbol Name Sector Weight Return Contribution QoQ
UNH UNITEDHEALTH GROUP INC Health Care 24.11% +12.24% +2.95% Hold
CI THE CIGNA GROUP Health Care 22.60% +10.42% +2.35% Reduce
AVTR AVANTOR INC Industrials 20.50% +1.79% +0.37% New
VSTS VESTIS CORPORATION Consumer Discretionary 15.67% +2.47% +0.39% Reduce
BBIO BRIDGEBIO PHARMA INC Health Care 13.52% +17.57% +2.38% Reduce
MAZE MAZE THERAPEUTICS INC Health Care 3.61% +24.72% +0.89% New
Contribution rank Symbol Sector Weight Return Contribution
1 UNH Health Care 24.11% +12.24% +2.95%
2 BBIO Health Care 13.52% +17.57% +2.38%
3 CI Health Care 22.60% +10.42% +2.35%
4 MAZE Health Care 3.61% +24.72% +0.89%
5 VSTS Consumer Discretionary 15.67% +2.47% +0.39%
6 AVTR Industrials 20.50% +1.79% +0.37%

7. Conclusions

  1. Over the attribution window 2026-09-30 → 2026-11-16 (33 trading days), the reported portfolio returned +9.54%, versus -17.01% for the QQQ synthetic benchmark — an excess of +26.55%.
  2. Return attribution: the largest positive style/industry contributions came from Residual Volatility +4.56%, Health Care +4.46%, Historical Volatility +2.52%; the largest drags came from Skewness -3.61%, Mid Cap -2.43%, Turnover -2.16%. Specific (stock-level) return contributed +1.97%.
  3. Risk attribution: Barra model volatility is 26.47% annualised; factor risk explains 54% of variance and specific risk 46%. The largest factor risk sources are Health Care 19.0%, Mid Cap 8.4%, Industrials 4.6%.
  4. Style tilt: size -0.62, momentum +0.45, volatility -0.18, liquidity -0.18; the weighted raw beta is 0.64. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
  5. Industry: the largest overweight versus the benchmark is Health Care (+62.1 pp), the largest underweight is Information Technology (-73.6 pp). Allocation contributed +22.47%, selection +16.35% and interaction -13.79%.
  6. Concentration: the top-10 positions are 100.0% of the attributed portfolio and the model covers 100.0% of its value with full style exposures. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
  • 13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
  • Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
  • Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
  • The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
  • Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
  • 13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
  • Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.

FAQ

What did BOONE CAPITAL MANAGEMENT LLC buy in 2026-Q3?

In its 2026-Q3 13F filing, BOONE CAPITAL MANAGEMENT LLC reported 16 equity positions worth $376.70M in aggregate; its largest disclosed positions were BMRN ($40.32M), TFX ($36.12M), MIRM ($35.53M).

How large is BOONE CAPITAL MANAGEMENT LLC's portfolio?

BOONE CAPITAL MANAGEMENT LLC reported $376.70M of long equity holdings across 16 positions as of 2026-Q3. Top-10 holdings account for 81.1% of reported value.

What is BOONE CAPITAL MANAGEMENT LLC's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/boone-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →